TY - JOUR
T1 - Healthcare professionals’ attitudes to mandatory COVID-19 vaccination
T2 - Cross-sectional survey data from four European countries
AU - Karlsson, Linda C.
AU - Garrison, Amanda
AU - Holford, Dawn
AU - Fasce, Angelo
AU - Lewandowsky, Stephan
AU - Taubert, Frederike
AU - Schmid, Philipp
AU - Betsch, Cornelia
AU - Rodrigues, Fernanda
AU - Fressard, Lisa
AU - Verger, Pierre
AU - Soveri, Anna
PY - 2023/9/19
Y1 - 2023/9/19
N2 - Mandatory vaccinations are widely debated since they restrict individuals’ autonomy in their health decisions. As healthcare professionals (HCPs) are a common target group of vaccine mandates, and also form a link between vaccination policies and the public, understanding their attitudes toward vaccine mandates is important. The present study investigated physicians’ attitudes to COVID-19 vaccine mandates in four European countries: Finland, France, Germany, and Portugal. An electronic survey assessing attitudes to COVID-19 vaccine mandates and general vaccination attitudes (e.g. perceived vaccine safety, trust in health authorities, and openness to patients) was sent to physicians in the spring of 2022. A total of 2796 physicians responded. Across all countries, 78% of the physicians were in favor of COVID-19 vaccine mandates for HCPs, 49% favored COVID-19 vaccine mandates for the public, and 67% endorsed COVID-19 health passes. Notable differences were observed between countries, with attitudes to mandates found to be more positive in countries where the mandate, or similar mandates, were in effect. The associations between attitudes to mandates and general vaccination attitudes were mostly small to neglectable and differed between countries. Nevertheless, physicians with more positive mandate attitudes perceived vaccines as more beneficial (in Finland and France) and had greater trust in medical authorities (in France and Germany). The present study contributes to the body of research within social and behavioral sciences that support evidence-based vaccination policymaking.
AB - Mandatory vaccinations are widely debated since they restrict individuals’ autonomy in their health decisions. As healthcare professionals (HCPs) are a common target group of vaccine mandates, and also form a link between vaccination policies and the public, understanding their attitudes toward vaccine mandates is important. The present study investigated physicians’ attitudes to COVID-19 vaccine mandates in four European countries: Finland, France, Germany, and Portugal. An electronic survey assessing attitudes to COVID-19 vaccine mandates and general vaccination attitudes (e.g. perceived vaccine safety, trust in health authorities, and openness to patients) was sent to physicians in the spring of 2022. A total of 2796 physicians responded. Across all countries, 78% of the physicians were in favor of COVID-19 vaccine mandates for HCPs, 49% favored COVID-19 vaccine mandates for the public, and 67% endorsed COVID-19 health passes. Notable differences were observed between countries, with attitudes to mandates found to be more positive in countries where the mandate, or similar mandates, were in effect. The associations between attitudes to mandates and general vaccination attitudes were mostly small to neglectable and differed between countries. Nevertheless, physicians with more positive mandate attitudes perceived vaccines as more beneficial (in Finland and France) and had greater trust in medical authorities (in France and Germany). The present study contributes to the body of research within social and behavioral sciences that support evidence-based vaccination policymaking.
KW - attitudes
KW - compulsory vaccination
KW - COVID-19
KW - Europe
KW - HCPs
KW - healthcare professionals
KW - mandates
KW - reactance
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=85171859713&partnerID=8YFLogxK
U2 - 10.1080/21645515.2023.2256442
DO - 10.1080/21645515.2023.2256442
M3 - Article
C2 - 37724556
AN - SCOPUS:85171859713
SN - 2164-5515
VL - 19
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 2
M1 - 2256442
ER -